![Dennis L. Guberski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dennis L. Guberski
Chairman at Biomedical Research Models, Inc.
Network origin in Dennis L. Guberski first degree
Entity | Entity type | Industry | |
---|---|---|---|
Biomedical Research Models, Inc.
![]() Biomedical Research Models, Inc. BiotechnologyHealth Technology Biomedical Research Models, Inc. develops and utilizes specialty animal models to determine the efficacy of new drugs in preventing or ameliorating human diseases. It offers contract research, proprietary models,colony management, and partnership services. The company was founded by Dennis L. Guberski in 1996 and is headquartered in Worcester, MA.
11
| Subsidiary | Biotechnology | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dennis L. Guberski via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Centocor, Inc.
![]() Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
W WORL | Pharmaceuticals: Major | Corporate Officer/Principal | |
Charles River Laboratories, Inc.
![]() Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Azaya Therapeutics, Inc.
![]() Azaya Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Azaya Therapeutics, Inc. develops pharmaceutical products and systems. The firm offers contract development and manufacturing services, such as chemical testing, liposomal manufacturing services to speed drug development and regulatory progress for pharmaceutical, medical device developers and meet customers’ academic or commercial needs. The company was founded by John C. Kerr in 2003 and is headquartered in San Antonio, TX. | Pharmaceuticals: Major | Founder | |
Evestra, Inc.
![]() Evestra, Inc. BiotechnologyHealth Technology Evestra, Inc. provides biopharmaceutical research and development services. It focuses in conducting research and product development in women's healthcare. The firm is involved in addressing unmet medical need in the areas of endometriosis, fibroids, hormone replacement therapy (HRT), and hormonal-dependent breast cancer. The company was founded by Ze’ev Shaked and Klaus Nickisch in October 2007 and is headquartered in Schertz, TX. | Biotechnology | Chairman | |
Stanford University | College/University | Undergraduate Degree | |
The University of Texas at Austin | College/University | Graduate Degree | |
The Pennsylvania State University | College/University | Doctorate Degree | |
University of Connecticut | College/University | Doctorate Degree | |
University of Massachusetts | College/University | Corporate Officer/Principal | |
The Children's Hospital Corp.
![]() The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Children's Hospital Corp. engages in the provision of pediatric care services. It offers acupuncture, angioplasty, antibiotic allergy testing, audiogram, baclofen pump, biochemical genetic testing, blended diet, bone scan, brain scan, breast augmentation surgery, cardiac catheterization, cardiac MRI in children, chest reconstruction surgery, and CO2 laser treatment. The company was founded by Francis Henry Brown in 1869 and is headquartered in Boston, MA. | Medical/Nursing Services | Corporate Officer/Principal | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree | |
SelectX Pharmaceuticals, Inc.
![]() SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Brava Therapeutics | Director/Board Member | ||
Texas Biomedical Research Institute | Miscellaneous Commercial Services | Director/Board Member | |
Chinese Academy of Preventive Medicine | College/University | Doctorate Degree | |
TransPecos Financial Corp.
![]() TransPecos Financial Corp. Financial ConglomeratesFinance TransPecos Financial Corp. bank holding company. The company is headquartered in San Antonio, TX. | Financial Conglomerates | Director/Board Member | |
Oral Vaccine Institute | Chief Tech/Sci/R&D Officer |
Statistics
International
United States | 22 |
Israel | 2 |
China | 2 |
Sectoral
Consumer Services | 8 |
Health Technology | 7 |
Commercial Services | 5 |
Finance | 4 |
Health Services | 2 |
Operational
Corporate Officer/Principal | 11 |
Director/Board Member | 8 |
Chairman | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 3 |
Most connected contacts
Insiders | |
---|---|
John C. Kerr | 11 |
Mark Nedelman | 4 |
Kejian Yang | 4 |
Barak Yahalom | 4 |
Barbara J. Whalen | 3 |
R. Norman Peters | 2 |
Christian Grant | 2 |
Thomas C. Lynch | 1 |
Paul E. Dinino | 1 |
Mary Gardner | 1 |
Gerald Tipper | 1 |
- Stock Market
- Insiders
- Dennis L. Guberski
- Company connections